ATNM - Actinium Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

ATNM is currently covered by 1 analysts with an average potential upside of $42.98 (510.35%) from yesterday's end of day stock price of $4.58. Actinium Pharmaceuticals activity chart has currently 0 price targets and 9 ratings on display.

Stock Analyst Price Targets - Review

Highest price target for ATNM is $13, Lowest price target is $6, average price target is $9.5.

Most recent stock forecast was given by JOSEPH PANTGINIS from HCWAINWRIGHT on 07-Sep-2023. First documented stock forecast 04-Jun-2020.

Best performing analysts who are covering ATNM - Actinium Pharmaceuticals:

Joseph Pantginis

Currently, out of the existing stock ratings of ATNM - 6 which are a Buy (100%)

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$45.42 (991.70%)


2 months 27 days ago

0/6 (0%)

$42.98 (510.35%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ATNM (Actinium Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ATNM (Actinium Pharmaceuticals) with a proven track record?


Which analyst has the most public recommendations on ATNM (Actinium Pharmaceuticals)?

Joseph Pantginis works at HC WAINWRIGHT and has 0 price targets and 1 ratings on ATNM

Which analyst is the currently most bullish on ATNM (Actinium Pharmaceuticals)?

Joseph Pantginis with highest potential upside - $45.42

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart